Literature DB >> 27497153

Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.

Alexa Orand1, Bruce Naliboff1, Malin Gadd2, Wendy Shih3, Tiffany Ju1, Angela P Presson4, Emeran A Mayer1, Lin Chang5.   

Abstract

BACKGROUND: Corticotropin-releasing hormone receptor 1 (CRH-R1) in the amygdala and the stria terminalis plays an important role in the activation of central stress circuits. Genetic factors may contribute to the hyperresponsiveness of these circuits in irritable bowel syndrome (IBS). AIMS: To determine if CRH-R1 SNPs are associated with: (1) a diagnosis of IBS, (2) gastrointestinal (GI) symptoms, and (3) acoustic startle response (ASR) to threat, which is mediated by the amygdala via CRH.
METHODS: Three CRH-R1 SNPS (rs110402, rs242924, and rs7209436) were genotyped using salivary DNA from IBS and healthy control subjects (HCs). Eye blink ASR was obtained during safe (no shock), anticipation (abdominal shock may soon occur) and threat (abdominal shock likely) conditions in a subset of subjects. Associations between each SNP with IBS status, clinical traits and ASR were measured.
RESULTS: 235 IBS patients (mean age 37.5 yrs, 74% F) and 264 HCs (mean age 32.1 yrs, 70% F) were studied. Of these, 57 IBS and 41 HCs underwent the ASR protocol. The presence of IBS was associated with the major allele for all three CRH-R1 SNPs (p=0.009-0.025). Within IBS, the major allele for all three SNPs (p=0.017-0.065) was associated with GI symptom anxiety scores. Within subjects with at least one copy of the major allele for the CRH-R1 SNPs, IBS had significantly lower ASR compared to HCs during threat conditions (p=0.001-0.002). Within IBS, CRH-R1 SNPs were associated with a graded increase in ASR to threat (p=0.007-0.008).
CONCLUSION: These findings support that CRH-R1 contributes to the dysregulated stress responsiveness in IBS.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acoustic startle response; Corticotropin releasing hormone receptor 1; Genetic polymorphism; Irritable bowel syndrome

Mesh:

Substances:

Year:  2016        PMID: 27497153      PMCID: PMC5048544          DOI: 10.1016/j.psyneuen.2016.07.204

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  48 in total

1.  Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.

Authors:  Lee Tran; Jay Schulkin; Beverley Greenwood-Van Meerveld
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

2.  The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.

Authors:  Jennifer S Labus; Emeran A Mayer; Lin Chang; Roger Bolus; Bruce D Naliboff
Journal:  Psychosom Med       Date:  2007-01       Impact factor: 4.312

Review 3.  Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.

Authors:  Shin Fukudo
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

4.  Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.

Authors:  Audrey R Tyrka; Lawrence H Price; Joel Gelernter; Caroline Schepker; George M Anderson; Linda L Carpenter
Journal:  Biol Psychiatry       Date:  2009-07-12       Impact factor: 13.382

5.  Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension.

Authors:  K Saito-Nakaya; R Hasegawa; Y Nagura; H Ito; S Fukudo
Journal:  Neurogastroenterol Motil       Date:  2008-08-28       Impact factor: 3.598

6.  Experimental assessment of affective processing in fibromyalgia.

Authors:  Emily J Bartley; Jamie L Rhudy; Amy E Williams
Journal:  J Pain       Date:  2009-07-24       Impact factor: 5.820

7.  Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.

Authors:  Sergi Papiol; Bárbara Arias; Cristóbal Gastó; Blanca Gutiérrez; Rosa Catalán; Lourdes Fañanás
Journal:  J Affect Disord       Date:  2007-04-30       Impact factor: 4.839

8.  Age, Gender and Women's Health and the Patient.

Authors:  Lesley A Houghton; Margaret Heitkemper; Michael Crowell; Anton Emmanuel; Albena Halpert; James A McRoberts; Brenda Toner
Journal:  Gastroenterology       Date:  2016-02-15       Impact factor: 22.682

Review 9.  Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Nora Hamdani; Wahid Boukouaci; Aroldo Dargel; José Oliveira; Matthieu Roger; Ryad Tamouza; Marion Leboyer; Laurent Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04-06       Impact factor: 5.270

10.  Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene.

Authors:  Rebekah G Bradley; Elisabeth B Binder; Michael P Epstein; Yilang Tang; Hemu P Nair; Wei Liu; Charles F Gillespie; Tiina Berg; Mark Evces; D Jeffrey Newport; Zachary N Stowe; Christine M Heim; Charles B Nemeroff; Ann Schwartz; Joseph F Cubells; Kerry J Ressler
Journal:  Arch Gen Psychiatry       Date:  2008-02
View more
  3 in total

Review 1.  Don't stress about CRF: assessing the translational failures of CRF1antagonists.

Authors:  Samantha R Spierling; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

2.  Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.

Authors:  Shin Fukudo; Toshikatsu Okumura; Masahiko Inamori; Yusuke Okuyama; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Akiko Shiotani; Yuji Naito; Yoshiko Fujikawa; Ryota Hokari; Tastuhiro Masaoka; Kazuma Fujimoto; Hiroshi Kaneko; Akira Torii; Kei Matsueda; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-02-04       Impact factor: 7.527

Review 3.  Corticotropin-Releasing Factor Family: A Stress Hormone-Receptor System's Emerging Role in Mediating Sex-Specific Signaling.

Authors:  Lahari Vuppaladhadiam; Cameron Ehsan; Meghana Akkati; Aditi Bhargava
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.